Related Experiment Video
Updated: Aug 29, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
[Prospective study of rotavirus infections in Belém, Pará, Brazil: clinical and epidemiological features]
A C Linhares1, Y B Gabbay, J D Mascarenhas
1Instituto Evandro Chagas-Fundação Nacional de Saúde do Ministério sa Saúde, Belém, Pará, Brazil.
Insights
This study assessed the Rhesus-human reassortant rotavirus (RRV-TV) vaccine's effectiveness in Brazilian children. Rotavirus was linked to severe diarrhea, with serotype 1 being most common, highlighting the need for rotavirus vaccination.
Area of Science:
- * Tropical Medicine
- * Pediatrics
- * Vaccinology
Background:
- * Acute diarrheal diseases pose a significant health burden, particularly in developing regions.
- * Rotavirus is a leading cause of severe diarrhea in children globally and in the Amazon region.
- * Understanding rotavirus epidemiology and clinical presentation is crucial for public health interventions.
Purpose of the Study:
- * To evaluate the immunogenicity, safety, and efficacy of the Rhesus-human reassortant rotavirus (RRV-TV) vaccine.
- * To expand knowledge on the clinical and epidemiological characteristics of rotavirus infections in the Amazon region.
- * To identify prevalent rotavirus serotypes and co-infections associated with acute diarrhea.
Main Methods:
- * A prospective study involving 540 children in Belém, Pará, Brazil, from April 1990 to September 1992.
- * A placebo-controlled trial design to assess vaccine efficacy and safety.
- * Monitoring of diarrheal episodes, pathogen identification (including rotavirus serotyping), and clinical severity scoring.
Main Results:
- * Rotavirus was identified in 86 (3.1%) of 2,789 diarrheal episodes; serotype 1 was most prevalent (67.9%).
- * Rotavirus-related diarrhea occurred at a rate of 0.2 episodes per child/year and was more severe than diarrhea of other etiologies.
- * Common co-infections included Giardia intestinalis and enteropathogenic Escherichia coli; rotavirus-related diarrhea peaked during dry months.
Conclusions:
- * The RRV-TV vaccine trial provided valuable data on rotavirus in the Amazon region.
- * Rotavirus, particularly serotype 1, is a significant cause of severe childhood diarrhea in this area.
- * Findings support the importance of rotavirus surveillance and vaccination programs in tropical regions.
Abstract:
A prospective study of acute diarrhoeal diseases was carried out from April 1990 to September 1992 with the purpose of assessing the immunogenicity, safety and efficacy of a Rhesus-human reassortant rotavirus ("RRV-TV") vaccine, involving 540 children living in Belém, Pará, Brazil. As half of the children received placebo, this trial provided the opportunity of broadening the knowledge on both clinical and epidemiological aspects of rotavirus infection in the Amazon region. There were 2,789 diarrhoeal episodes during the above mentioned period, of which 86 (3.1%) associated with rotavirus; serotype 1 was the more prevalent, accounting for 67.9% of serotyped strains. Rates of 5.9 and 0.2 episodes of diarrhoea per child/year were noted for all cases and the rotavirus-related ones, respectively. This agent was the only pathogen found in 70.9% of the 86 rotavirus-related episodes of acute diarrhoea, whereas the most frequent associations involved Giardia intestinalis and enteropathogenic Escherichia coli, accounting for 7.0% and 11.6% of mixed infections,respectively. The monthly rates of rotavirus-related episodes of diarrhoea ranged from 0.8% to 9.6%, reaching the highest peaks during the dry months of the year. Means of clinical severity scores of 9.4 and 5.3 were recorded for the rotavirus-related episodes of diarrhoea and those of other aetiology, respectively.
Related Concept Videos
Bacterial Gastroenteritis
Respiratory Syncytial Virus Disease
Poliomyelitis
Botulism
Cholera
